Stockreport

Viking's VK2809 shows positive effect in POC study in glycogen storage disease; shares ahead 10% premarket [Seeking Alpha]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF Preliminary results from a proof-of-concept (POC) study assessing Viking Therapeutics' (NASDAQ: VKTX ) VK2809 in an in vivo model of a rare orphan disorder calle [Read more]